495 related articles for article (PubMed ID: 9707504)
1. Nephrotoxicity of cadmium-metallothionein: protection by zinc and role of glutathione.
Tang W; Sadovic S; Shaikh ZA
Toxicol Appl Pharmacol; 1998 Aug; 151(2):276-82. PubMed ID: 9707504
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein plays less of a protective role in cadmium-metallothionein-induced nephrotoxicity than in cadmium chloride-induced hepatotoxicity.
Liu J; Liu Y; Michalska AE; Choo KH; Klaassen CD
J Pharmacol Exp Ther; 1996 Mar; 276(3):1216-23. PubMed ID: 8786554
[TBL] [Abstract][Full Text] [Related]
3. Cadmium-Metallothionein nephropathy: relationships between ultrastructural/biochemical alterations and intracellular cadmium binding.
Squibb KS; Pritchard JB; Fowler BA
J Pharmacol Exp Ther; 1984 Apr; 229(1):311-21. PubMed ID: 6707945
[TBL] [Abstract][Full Text] [Related]
4. Dependence of cadmium-metallothionein nephrotoxicity on glutathione.
Shaikh ZA; Northup JB; Vestergaard P
J Toxicol Environ Health A; 1999 Jun; 57(3):211-22. PubMed ID: 10376887
[TBL] [Abstract][Full Text] [Related]
5. Protection by zinc-metallothionein (ZnMT) against cadmium-metallothionein-induced nephrotoxicity.
Dorian C; Klaassen CD
Fundam Appl Toxicol; 1995 Jun; 26(1):99-106. PubMed ID: 7657068
[TBL] [Abstract][Full Text] [Related]
6. Rat hepatocytes with elevated metallothionein expression are resistant to N-methyl-N'-nitro-N-nitrosoguanidine cytotoxicity.
Moffatt P; Plaa GL; Denizeau F
Toxicol Appl Pharmacol; 1996 Jan; 136(1):200-7. PubMed ID: 8560476
[TBL] [Abstract][Full Text] [Related]
7. Discrepancy between the nephrotoxic potencies of cadmium-metallothionein and cadmium chloride and the renal concentration of cadmium in the proximal convoluted tubules.
Dorian C; Gattone VH; Klaassen CD
Toxicol Appl Pharmacol; 1995 Jan; 130(1):161-8. PubMed ID: 7839364
[TBL] [Abstract][Full Text] [Related]
8. The nephrotoxicity of intravenously administered cadmium-metallothionein: effect of dose, mode of administration, and preexisting renal cadmium burden.
Vestergaard P; Shaikh ZA
Toxicol Appl Pharmacol; 1994 Jun; 126(2):240-7. PubMed ID: 8209377
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of MT-null mice to chronic CdCl2-induced nephrotoxicity indicates that renal injury is not mediated by the CdMT complex.
Liu J; Liu Y; Habeebu SS; Klaassen CD
Toxicol Sci; 1998 Nov; 46(1):197-203. PubMed ID: 9928683
[TBL] [Abstract][Full Text] [Related]
10. Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats.
Liu J; Habeebu SS; Liu Y; Klaassen CD
Toxicol Appl Pharmacol; 1998 Nov; 153(1):48-58. PubMed ID: 9875299
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein-I-transgenic mice are not protected from acute cadmium-metallothionein-induced nephrotoxicity.
Liu YP; Liu J; Palmiter RD; Klaassen CD
Toxicol Appl Pharmacol; 1996 Apr; 137(2):307-15. PubMed ID: 8661357
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein protects against the nephrotoxicity produced by chronic CdMT exposure.
Liu Y; Liu J; Habeebu SS; Klaassen CD
Toxicol Sci; 1999 Aug; 50(2):221-7. PubMed ID: 10478858
[TBL] [Abstract][Full Text] [Related]
13. Nephrotoxicity of repeated injections of cadmium-metallothionein in rats.
Wang XP; Chan HM; Goyer RA; Cherian MG
Toxicol Appl Pharmacol; 1993 Mar; 119(1):11-6. PubMed ID: 8470114
[TBL] [Abstract][Full Text] [Related]
14. Role of metallothionein in cadmium traffic and toxicity in kidneys and other mammalian organs.
Sabolić I; Breljak D; Skarica M; Herak-Kramberger CM
Biometals; 2010 Oct; 23(5):897-926. PubMed ID: 20549307
[TBL] [Abstract][Full Text] [Related]
15. Distribution and retention of cadmium in metallothionein I and II null mice.
Liu J; Liu Y; Michalska AE; Choo KH; Klaassen CD
Toxicol Appl Pharmacol; 1996 Feb; 136(2):260-8. PubMed ID: 8619234
[TBL] [Abstract][Full Text] [Related]
16. Basal and zinc-induced metallothionein in resistance to cadmium, cisplatin, zinc, and tertbutyl hydroperoxide: studies using MT knockout and antisense-downregulated MT in mammalian cells.
Kennette W; Collins OM; Zalups RK; Koropatnick J
Toxicol Sci; 2005 Dec; 88(2):602-13. PubMed ID: 16150881
[TBL] [Abstract][Full Text] [Related]
17. Kidney synthesizes less metallothionein than liver in response to cadmium chloride and cadmium-metallothionein.
Sendelbach LE; Klaassen CD
Toxicol Appl Pharmacol; 1988 Jan; 92(1):95-102. PubMed ID: 3341030
[TBL] [Abstract][Full Text] [Related]
18. Renal accumulation of cadmium and nephropathy following long-term administration of cadmium-metallothionein.
Min KS; Onosaka S; Tanaka K
Toxicol Appl Pharmacol; 1996 Nov; 141(1):102-9. PubMed ID: 8917681
[TBL] [Abstract][Full Text] [Related]
19. Effects of glutathione depletion on cadmium-induced metallothionein synthesis, cytotoxicity, and proto-oncogene expression in cultured rat myoblasts.
Shimizu M; Hochadel JF; Waalkes MP
J Toxicol Environ Health; 1997 Aug; 51(6):609-21. PubMed ID: 9242231
[TBL] [Abstract][Full Text] [Related]
20. Induction of hepatic and renal metallothionein synthesis by ferric nitrilotriacetate in mice: the role of MT as an antioxidant.
Min KS; Morishita F; Tetsuchikawahara N; Onosaka S
Toxicol Appl Pharmacol; 2005 Apr; 204(1):9-17. PubMed ID: 15781289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
